HBK Sorce Advisory »

Heron Therapeutics shares owned by HBK Sorce Advisory

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by HBK Sorce Advisory from 13F filings

Historical chart of HBK Sorce Advisory investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by HBK Sorce Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by HBK Sorce Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 10k 1.26
2025-09-30 $14k 10k 1.35

More positions owned by HBK Sorce Advisory

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Large Cap Vec (DFVX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for HBK Sorce Advisory

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics